Organization: Health Canada
Year: 2022
Month: December
Request Number: A-2022-000548
Request Summary: Adverse Drug Reactions (ADRs) for MESALAZINE. Report numbers: 000990672, E2B_05361971, E2B_05323624, E2B_05368162, 000992474. ADRs for VYVANSE. Report numbers: E2B_05347288, 000992979. ADRs for C1 ESTERASE INHIBITOR (HUMAN). Report numbers: E2B_05309974, E2B_05344993, E2B_05349867.
Disposition: Disclosed in part
Number of pages: 542